Cooke Julie Insider Trades

Insider Trading History

Track insider trading activity for Cooke Julie. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $9.58M 59,311 shares
Last Trade
Jun 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.87M 24,965 shares
$154.84
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $7.28M 45,097 shares
Last Trade
Jun 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.77M 36,937 shares
$156.22
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $0 0 shares
Last Trade
Jun 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.87M 24,965 shares
$154.84
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $452k 2,802 shares
Last Trade
Feb 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$361k 2,911 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $4.91M 30,395 shares
Last Trade
Feb 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$361k 2,911 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $6.38M 39,548 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.19M 41,822 shares
$124.00
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $5.52M 34,170 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$863k 6,949 shares
$124.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $4.56M 28,240 shares
Last Trade
Feb 12, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$92.2k 749 shares
$123.10
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $672k 4,161 shares
Last Trade
Feb 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 1,387 shares
$123.10
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $4.68M 28,989 shares
Last Trade
Feb 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 1,387 shares
$123.10
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $0 0 shares
Last Trade
Jan 31, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$237k 1,741 shares
$136.06
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $4.62M 28,599 shares
Last Trade
Jan 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$237k 1,741 shares
$136.06
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $4.46M 27,602 shares
Last Trade
Jan 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$136k 997 shares
$136.06
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $0 0 shares
Last Trade
May 16, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$783k 6,468 shares
$121.02
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $4.34M 26,858 shares
Last Trade
May 16, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$783k 6,468 shares
$121.02
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $3.26M 20,190 shares
Last Trade
Feb 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$181k 1,551 shares
$116.78
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $4.78M 29,600 shares
Last Trade
Feb 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.47M 29,600 shares
$117.18
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $3.04M 18,831 shares
Last Trade
Feb 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$82.8k 700 shares
$118.28
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $0 0 shares
Last Trade
Feb 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$163k 1,329 shares
$122.62
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Human Resources Officer
Holding Value $3.15M 19,531 shares
Last Trade
Feb 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$163k 1,329 shares
$122.62
$161.44

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up